262 related articles for article (PubMed ID: 34712487)
1. A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer.
Wang L; Chang N; Wu L; Li J; Zhang L; Chen Y; Zhou Z; Hao J; Wang Q; Jiao S
Mol Clin Oncol; 2021 Dec; 15(6):257. PubMed ID: 34712487
[TBL] [Abstract][Full Text] [Related]
2. A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy.
Duan J; Xie Y; Qu L; Wang L; Zhou S; Wang Y; Fan Z; Yang S; Jiao S
J Immunother Cancer; 2018 Oct; 6(1):100. PubMed ID: 30285868
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.
Ren J; Xu L; Zhou S; Ouyang J; You W; Sheng N; Yan L; Peng D; Xie L; Wang Z
Front Oncol; 2021; 11():776997. PubMed ID: 34926285
[TBL] [Abstract][Full Text] [Related]
4. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for predicting overall survival time of patients with stage IV colorectal cancer.
Lv MY; Chen XJ; Chen JG; Zhang B; Lin YY; Huang TZ; He DG; Wang K; Chi ZJ; Hu JC; He XS
Gastroenterol Rep (Oxf); 2022; 10():goac072. PubMed ID: 36518985
[TBL] [Abstract][Full Text] [Related]
6. Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients.
Kou FR; Zhang YZ; Xu WR
World J Clin Cases; 2021 Apr; 9(11):2503-2518. PubMed ID: 33889615
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of preoperative D-dimer to albumin ratio for overall survival and progression-free survival in colorectal cancer.
Wei L; Xie H; Wang Q; Tang S; Gan J
Front Physiol; 2024; 15():1369855. PubMed ID: 38487266
[No Abstract] [Full Text] [Related]
8. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer.
Zhou S; He Q; Sheng N; Gong J; Ren J; Wang Z
World J Surg Oncol; 2022 Jan; 20(1):18. PubMed ID: 35033097
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a prognostic nomogram for colorectal cancer after surgery.
Li BW; Ma XY; Lai S; Sun X; Sun MJ; Chang B
World J Clin Cases; 2021 Jul; 9(21):5860-5872. PubMed ID: 34368305
[TBL] [Abstract][Full Text] [Related]
10. A novel nutrition-related nomogram for the survival prediction of colorectal cancer-results from a multicenter study.
Ruan GT; Song MM; Zhang KP; Xie HL; Zhang Q; Zhang X; Tang M; Zhang XW; Ge YZ; Yang M; Zhu LC; Shi HP
Nutr Metab (Lond); 2023 Jan; 20(1):2. PubMed ID: 36600242
[TBL] [Abstract][Full Text] [Related]
11. Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer.
Mo S; Zhou Z; Li Y; Hu X; Ma X; Zhang L; Cai S; Peng J
Cancer Cell Int; 2020; 20():285. PubMed ID: 32655317
[TBL] [Abstract][Full Text] [Related]
12. Increased prognostic value of clinical-reproductive model in Chinese female patients with esophageal squamous cell carcinoma.
Zhang DY; Ku JW; Zhao XK; Zhang HY; Song X; Wu HF; Fan ZM; Xu RH; You D; Wang R; Zhou RX; Wang LD
World J Gastroenterol; 2022 Apr; 28(13):1347-1361. PubMed ID: 35645543
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Tumor Deposit Counts in Patients with Stage III Colorectal Cancer: A Population-Based Study.
Long Q; Xu Y; Ma G; Mao W
J Invest Surg; 2022 Jul; 35(7):1502-1509. PubMed ID: 35508325
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting the overall survival of underweight patients with colorectal cancer: a clinical study.
Bong JW; Na Y; Ju Y; Cheong C; Kang S; Lee SI; Min BW
BMC Gastroenterol; 2023 Feb; 23(1):39. PubMed ID: 36782150
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nomograms integrating preoperative serum lipid derivative and systemic inflammatory marker of patients with non-metastatic colorectal cancer undergoing curative resection.
Huang D; Zheng S; Huang F; Chen J; Zhang Y; Chen Y; Li B
Front Oncol; 2023; 13():1100820. PubMed ID: 36969019
[TBL] [Abstract][Full Text] [Related]
17. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
[TBL] [Abstract][Full Text] [Related]
18. Performance of a Nomogram Based on the Integration of Inflammation Markers with Tumor Staging in Prognosis Prediction of Stage III Colorectal Cancer.
Wang L; Xiao J; Li MZ; Teng WH; Jia J; Lin L; Liu S; Ye XM; Zang WD; Chen Y
Cancer Manag Res; 2020; 12():7077-7085. PubMed ID: 32821170
[TBL] [Abstract][Full Text] [Related]
19. A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer.
Wen T; Wang Z; Li Y; Li Z; Che X; Fan Y; Wang S; Qu J; Yang X; Hou K; Zhou W; Xu L; Li C; Wang J; Liu J; Chen L; Zhang J; Qu X; Liu Y
Cancer Immunol Res; 2017 Jul; 5(7):524-534. PubMed ID: 28619967
[TBL] [Abstract][Full Text] [Related]
20. A Nomogram Based on Circulating CD4
Shen DS; Yan C; Chen KH; Li L; Qu S; Zhu XD
J Inflamm Res; 2021; 14():6707-6718. PubMed ID: 34916820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
